Baraclude (entecavir) is a small molecule pharmaceutical. Entecavir was first approved as Baraclude on 2005-03-29. It is used to treat chronic hepatitis b and hepatitis b in the USA. It has been approved in Europe to treat chronic hepatitis b and hepatitis b.
|Indication||chronic hepatitis b, hepatitis b|
|Drug Class||Antivirals: carbocyclic nucleosides|